Yue et al. discovered that LINC02154 promotes hepatocellular carcinoma proliferation and metastasis, by increasing SPC24 promoter activity and activating the PI3K-AKT signaling pathway (Yue et al., 2022). Here, AKT1 is linked to hepatocellular carcinoma.